15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering JBS N.V, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $18.00 to $20.00, so the covering firms are broadly aligned. The average target of $19.00 sits 37% above the current $13.91. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.18 next quarter toward $8.87 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to JBS N.V.
As of Jul, 3 of 3 firms rate JBS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
JBS EPS & revenue forecast
EPS · NEXT QUARTER
$2.18
Range $1.98 – $2.46 · 4 analysts · -24% YoY
Next period, 4 analysts expect JBS N.V. to earn $2.18 a share (range $1.98 – $2.46), versus $2.87 a year earlier. Full-year consensus is $7.14, growing to $8.87 the year after.
REVENUE · NEXT QUARTER
$122.0B
Range $118.6B – $124.1B · 4 analysts · -1% YoY
Revenue is expected to reach $122.0B (range $118.6B – $124.1B), -0.9% year-over-year. Full-year consensus is $469.3B, rising to $480.9B next year.
Top analysts covering JBS N.V.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on JBS.
#1
Benjamin Theurer
Barclays · Rank #72
Buy
$20.00+43.7% to target
Overall win rate
47%
+ Follow
#2
John Baumgartner
Mizuho · Rank #240
Buy
No targeton JBS
Overall win rate
30%
+ Follow
#3
Andrew Strelzik
BMO Capital · Rank #292
Buy
$20.00+43.7% to target
Overall win rate
37%
+ Follow
#4
LF
Lucas Ferreira
JP Morgan
Buy
$18.00+29.4% to target
Coverage
—
+ Follow
#5
PS
Pooran Sharma
Stephens & Co.
Buy
$18.00+29.4% to target
Coverage
—
+ Follow
JBS stock forecast FAQ
What is JBS's average 12-month price target?+
The 3 analysts with a live target average $19.00 for JBS N.V. over the next 12 months, ranging from a $20.00 high to a $18.00 low.
Is JBS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for JBS?+
The Street-high target is $20.00 (Barclays), and the Street-low is $18.00 (JP Morgan). The average of all 3 active targets is $19.00.
How many Wall Street analysts cover JBS?+
3 analysts have an active rating on JBS N.V., and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering JBS?+
Among analysts who currently cover JBS, Benjamin Theurer of Barclays has the strongest overall Quantellect track record (Rank #72). Their current call is Buy with a $20.00 target.
What is JBS N.V.'s projected EPS for next quarter?+
The consensus estimate is $2.18 per share (range $1.98 – $2.46) across 4 analysts. Full-year EPS is projected at $7.14, rising to $8.87 the following year.
How much revenue is JBS N.V. expected to report next quarter?+
Consensus revenue is $122.0B (range $118.6B – $124.1B). Full-year revenue is projected at $469.3B, growing to $480.9B next year.
Have analysts been upgrading or downgrading JBS lately?+
As of Jul, 3 of 3 firms rate JBS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their JBS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
